References
  1. Wu Z, McGoogan JM. Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China: Summary of a Report of 72314 Cases From the Chinese Center for Disease Control and Prevention. JAMA 2020.
  2. Ren LL, Wang YM, Wu ZQ, et al. Identification of a novel coronavirus causing severe pneumonia in human: a descriptive study. Chin Med J (Engl) 2020;133:1015-24.
  3. Del Rio C, Malani PN. 2019 Novel Coronavirus-Important Information for Clinicians. JAMA 2020.
  4. Bai Y, Yao L, Wei T, et al. Presumed Asymptomatic Carrier Transmission of COVID-19. JAMA 2020.
  5. https://www.cdc.gov/coronavirus/2019-ncov/index.html. CfDCaPCDC-SSAf.
  6. Shaker MS, Oppenheimer J, Grayson M, et al. COVID-19: Pandemic Contingency Planning for the Allergy and Immunology Clinic. J Allergy Clin Immunol Pract 2020;8:1477-88 e5.
  7. Brough HA, Kalayci O, Sediva A, et al. Managing childhood allergies and immunodeficiencies during respiratory virus epidemics - the 2020 COVID-19 pandemic. Pediatr Allergy Immunol 2020.
  8. Guerra FM, Bolotin S, Lim G, et al. The basic reproduction number (R0) of measles: a systematic review. Lancet Infect Dis 2017;17:e420-e8.
  9. Guan WJ, Ni ZY, Hu Y, et al. Clinical Characteristics of Coronavirus Disease 2019 in China. N Engl J Med 2020;382:1708-20.
  10. Dharmage SC, Perret JL, Custovic A. Epidemiology of Asthma in Children and Adults. Front Pediatr 2019;7:246.
  11. Zhang JJ, Dong X, Cao YY, et al. Clinical characteristics of 140 patients infected with SARS-CoV-2 in Wuhan, China. Allergy 2020.
  12. Korean Society of Infectious D, Korean Society of Pediatric Infectious D, Korean Society of E, et al. Report on the Epidemiological Features of Coronavirus Disease 2019 (COVID-19) Outbreak in the Republic of Korea from January 19 to March 2, 2020. J Korean Med Sci 2020;35:e112.
  13. Haberman R, Axelrad J, Chen A, et al. Covid-19 in Immune-Mediated Inflammatory Diseases - Case Series from New York. N Engl J Med 2020.
  14. Licari A, Votto M, Brambilla I, Castagnoli R, Piccotti E, Olcese R, et al. Allergy and asthma in children and adolescents during the COVID outbreak: What we know and how we could prevent allergy and asthma flares. Allergy. 2020 May 17. doi: 10.1111/all.14369.
  15. Vultaggio A. Considerations on Biologicals for Patients with allergic disease in times of the COVID-19 pandemic. Allergy 2020;in press.
  16. Epstein T. ADMINISTRATION OF SUBCUTANEOUS ALLERGEN IMMUNOTHERAPY DURING THE COVID-19 OUTBREAK: A Work Group Report of the AAAAI Immunotherapy, Allergen Standardization and Allergy Diagnostics (IASAD) Committee. 2020.
  17. Casale TB, Wang J, Nowak-Wegrzyn A. Acute At Home Management of Anaphylaxis During the Covid-19 Pandemic. J Allergy Clin Immunol Pract 2020.
  18. Nowak-Wegrzyn A, Cianferoni A, Bird JA, Fiocchi A, Caubet JC, Medical Advisory Board of the International FA. Managing food protein-induced enterocolitis syndrome during the coronavirus disease 2019 pandemic: Expert recommendations. Ann Allergy Asthma Immunol 2020.
  19. Groetch M, Durban R, Meyer R, Venter C, Nowak-Wegrzyn A. Dietary Management of Food Protein-Induced Enterocolitis Syndrome during COVID-19 Pandemic. Ann Allergy Asthma Immunol 2020.